PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+16.95%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.93B
AUM Growth
+$1.93B
(+10%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
191
New
20
Increased
30
Reduced
38
Closed
68
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$64.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$58.2M |
| 3 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$38M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$23.8M |
| 5 |
Intuitive Surgical
ISRG
|
$19.4M |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
$37.6M |
| 2 |
Sarepta Therapeutics
SRPT
|
$23M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$20.4M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14.6M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$12.6M |
Sector Composition
| 1 | Healthcare | 96.53% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Energy | 0.04% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $174M | 8.76% | 17,296,672 | – | – |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $165M | 8.28% | 3,577,589 +211,059 | +6% | +$9.71M |
|
|
3
Alnylam Pharmaceuticals
ALNY
$58.5B
| $146M | 7.36% | 1,832,761 +729,286 | +66% | +$58.2M |
|
|
GBT
4
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $108M | 5.41% | 3,933,927 +74,949 | +2% | +$2.05M |
|
|
ARAV
5
DELISTED
Aravive, Inc. Common Stock
ARAV
| $76.9M | 3.87% | 4,407,317 | – | – |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $64.2M | 3.23% | 2,157,011 +17,737 | +0.8% | +$528K |
|
|
7
Puma Biotechnology
PBYI
$254M
| $64.1M | 3.23% | +733,320 | New | +$64.1M |
|
8
Travere Therapeutics
TVTX
$1.56B
| $51.8M | 2.61% | 2,672,309 -135,216 | -5% | -$2.62M |
|
|
TSRO
9
DELISTED
TESARO, Inc.
TSRO
| $50.3M | 2.53% | 359,551 +118,523 | +49% | +$16.6M |
|
|
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
| $50M | 2.52% | 3,448,302 +1,245,000 | +57% | +$18.1M |
|
|
CORI
11
DELISTED
Corium International, Inc.
CORI
| $43.6M | 2.2% | 5,847,133 +3,192,648 | +120% | +$23.8M |
|
|
NXTM
12
DELISTED
NxStage Medical Inc.
NXTM
| $39M | 1.96% | 1,555,523 -262,666 | -14% | -$6.59M |
|
|
DOVA
13
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $38M | 1.91% | +1,706,499 | New | +$38M |
|
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $36.7M | 1.85% | 1,089,961 -681,068 | -38% | -$23M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $35.7M | 1.8% | 277,352 -16,157 | -6% | -$2.08M |
|
16
Iovance Biotherapeutics
IOVA
$807M
| $32.1M | 1.61% | 4,363,114 +795,561 | +22% | +$5.85M |
|
|
RDUS
17
DELISTED
Radius Health, Inc.
RDUS
| $29.2M | 1.47% | 645,873 -264,999 | -29% | -$12M |
|
|
VBIV
18
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $28.6M | 1.44% | 6,565,843 | – | – |
|
19
Xencor
XNCR
$580M
| $27.3M | 1.37% | 1,293,095 -313,923 | -20% | -$6.63M |
|
20
Evolent Health
EVH
$1.12B
| $27.2M | 1.37% | 1,074,327 -370,173 | -26% | -$9.38M |
|
21
Regenxbio
RGNX
$451M
| $27.1M | 1.36% | 1,371,186 -25,058 | -2% | -$495K |
|
|
QTNT
22
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $26M | 1.31% | 3,714,486 +796,701 | +27% | +$5.58M |
|
23
AnaptysBio
ANAB
$569M
| $22.8M | 1.15% | 952,269 +70,312 | +8% | +$1.68M |
|
|
BPMC
24
DELISTED
Blueprint Medicines
BPMC
| $22.5M | 1.13% | 444,661 -16,981 | -4% | -$860K |
|
|
AVXS
25
DELISTED
AveXis, Inc. Common Stock
AVXS
| $22.3M | 1.12% | 271,181 -177,320 | -40% | -$14.6M |
|